Boston Business Journal Report: Tokai Pharmaceuticals' IPO | NECN
NECN Business

NECN Business

Boston Business Journal Report: Tokai Pharmaceuticals' IPO

BBJ editor Don Seiffert talks about Tokai Pharmaceuticals' soaring IPO

    processing...

    NEWSLETTERS

    BBJ editor Don Seiffert talks about Tokai Pharmaceuticals' soaring IPO. (Published Wednesday, Sept. 17, 2014)

    There's lots of money moving around in the biotech field in Massachusetts.

    According to the Boston Business Journal, Tokai Pharmaceuticals shares soared after a $98 million IPO.

    BBJ editor Don Seiffert said there have been 14 biotech companies so far with IPOs, another one rolling its IPO out this week and three more before the end of the year.

    "If you think about it, that's 20 percent of the total biotech IPOs in the whole country are right here in the state," he said. 

    For up-to-the-minute news and weather, be sure to follow us on Twitter and like us on Facebook. Sign up for our new breaking news email alerts by clicking here and download our free apps here.